The university's most recent spin-out will develop 3D printing techniques to produce tissue-like synthetic materials.

OxSyBio, the latest Oxford University spin-out through its technology transfer company Isis Innovation, is aiming to develop 3D printing techniques that will produce tissue-like synthetic materials for wound healing and drug delivery. OxSyBio has raised £1m ($1.68m) from IP Group, a UK-based intellectual property commercialisation business. The funding is subject to the achievement of milestones. The company has a long-term goal of printing synthetic tissues for organ repair or replacement. 

OxSyBio is spun out from the university’s Department of Chemistry, and…